Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on: January 16,2024

Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on:January 16,2024

Young women often delay looking into breast symptoms, research finds

by Dennis ThompsonYoung women who find a lump or other potential signs of breast cancer often delay for weeks before finally seeing a doctor, a new study shows.On average, young women waited two weeks

Updated on: April 28,2024

Young women often delay looking into breast symptoms, research finds

by Dennis ThompsonYoung women who find a lump or other potential signs of breast cancer often delay for weeks before finally seeing a doctor, a new study shows.On average, young women waited two weeks

Updated on:April 28,2024

Research advances to better target debilitating effects of cachexia syndrome

by Medical University of South CarolinaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study published inCell ReportsAug.

Updated on: June 28,2024

Research advances to better target debilitating effects of cachexia syndrome

by Medical University of South CarolinaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study published inCell ReportsAug.

Updated on:June 28,2024

Trends in genitourinary cancers examined in the United States

by Elana GotkineThe highest incidence rates of bladder cancer are seen in the Northeast, while the West has the highest deaths rates for prostate cancer among non-Hispanic White men, according to a st

Updated on: January 02,2024

Trends in genitourinary cancers examined in the United States

by Elana GotkineThe highest incidence rates of bladder cancer are seen in the Northeast, while the West has the highest deaths rates for prostate cancer among non-Hispanic White men, according to a st

Updated on:January 02,2024

A new strategy 'raises the volume' of gut-body communication

by Ana María Rodríguez, Ph.d.,Baylor College of MedicineCredit: CC0 Public DomainThroughout the gastrointestinal tract there are specialized hormone-producing cells called enteroendocrine cells

Updated on: May 23,2024

A new strategy 'raises the volume' of gut-body communication

by Ana María Rodríguez, Ph.d.,Baylor College of MedicineCredit: CC0 Public DomainThroughout the gastrointestinal tract there are specialized hormone-producing cells called enteroendocrine cells

Updated on:May 23,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on: January 02,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on:January 02,2024

11 percent of cancers detected via emergency visit

About 11 percent of cancers are diagnosed following an emergency department visit, according to a study presented at the 12th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethn

Updated on: March 14,2024

11 percent of cancers detected via emergency visit

About 11 percent of cancers are diagnosed following an emergency department visit, according to a study presented at the 12th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethn

Updated on:March 14,2024

Pattern of hospital visits offers clue to spotting people at risk of myeloma

by National Cancer Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A condition that can progress to myeloma c

Updated on: May 13,2024

Pattern of hospital visits offers clue to spotting people at risk of myeloma

by National Cancer Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A condition that can progress to myeloma c

Updated on:May 13,2024

Overweight before age 40 increases cancer risk

by Kim E. Andreassen,University of BergenObesity is a risk factor for many types of cancer. Credit: Colourbox.In an international study, lead by the University of Bergen, the researchers wanted

Updated on: March 14,2024

Overweight before age 40 increases cancer risk

by Kim E. Andreassen,University of BergenObesity is a risk factor for many types of cancer. Credit: Colourbox.In an international study, lead by the University of Bergen, the researchers wanted

Updated on:March 14,2024

Study shines light on impact of environment on neurocognitive outcomes in survivors of pediatric brain tumors

by St. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainTo gain a clearer understanding of the differences between childhood cancer patients when it comes to the impact of ra

Updated on: February 01,2024

Study shines light on impact of environment on neurocognitive outcomes in survivors of pediatric brain tumors

by St. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainTo gain a clearer understanding of the differences between childhood cancer patients when it comes to the impact of ra

Updated on:February 01,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on: May 31,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on:May 31,2024

Immunotherapy was meant to defeat cancer—what happened to the great promise?

by Jonathan Fisher,The ConversationCredit: Ivan Samkov from PexelsIn 1893, theAmerican Journal of the Medical Sciencesreported on 10 patients whose large and hitherto incurable cance

Updated on: November 10,2024

Immunotherapy was meant to defeat cancer—what happened to the great promise?

by Jonathan Fisher,The ConversationCredit: Ivan Samkov from PexelsIn 1893, theAmerican Journal of the Medical Sciencesreported on 10 patients whose large and hitherto incurable cance

Updated on:November 10,2024